Kezar Life Sciences (FRA:2KZ) Accounts Payable & Accrued Expense : €9.09 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Kezar Life Sciences Accounts Payable & Accrued Expense?

Kezar Life Sciences's quarterly accounts payable & accrued expense declined from Sep. 2023 (€10.13 Mil) to Dec. 2023 (€10.01 Mil) and declined from Dec. 2023 (€10.01 Mil) to Mar. 2024 (€9.09 Mil).

Kezar Life Sciences's annual accounts payable & accrued expense increased from Dec. 2021 (€4.38 Mil) to Dec. 2022 (€4.63 Mil) and increased from Dec. 2022 (€4.63 Mil) to Dec. 2023 (€10.01 Mil).

Kezar Life Sciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kezar Life Sciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kezar Life Sciences Accounts Payable & Accrued Expense Chart

Kezar Life Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.23

3.17

4.38

4.63

10.01

Kezar Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															8.70	8.17	10.13	10.01	9.09

Kezar Life Sciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kezar Life Sciences (FRA:2KZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kezar Life Sciences Inc (FRA:2KZ) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

KZR:USA 2KZ:Germany

Address

4000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.kezarlifesciences.com

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.

Kezar Life Sciences (FRA:2KZ) Headlines

No Headlines